Personal Information
Entreprise/Lieu de travail
San Francisco Bay Area, Southern California United States
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.enlighten-cda.com
À propos
Dynamic, driven, and disruptive pioneer with proven deal closure results & leadership skills seeks to bolster strategic corporate development (Alliance/BD and M&A) and managerial proficiencies. Goals involve growing high revenue + market share and executing joint deals in broad Rx areas, followed by completing an EMBA program.
Completed a Ph.D. in synthetic chemistry & an NSF Postdoctoral Fellowship at the University of Pennsylvania. Leveraged this expertise in expediting the drug discovery process for natural products synthesis on oncology molecules such as (+)-Discodermalide.
STRATEGIC PLANNING:
Piloted 10+ year market plan initiatives for Biotechnology companies throughout the Rx eco...
Mots-clés
gene therapy
neuroscience
humanized animals
cloning
pharmacology
translational randd
stem cells
gene editing
in vitro
cell engineering
in vivo
preclinical
metabolism
genomics
asymmetric catalysis
peroxides
zinc
biotechnology and pharmaceuticals
titanium
pharmaceutical drug
metal-mediated reactions
Tout plus
Présentations
(2)Documents
(1)J’aime
(1)Bio partnering 2006_final
AVIVE, INC.
•
il y a 13 ans
Personal Information
Entreprise/Lieu de travail
San Francisco Bay Area, Southern California United States
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.enlighten-cda.com
À propos
Dynamic, driven, and disruptive pioneer with proven deal closure results & leadership skills seeks to bolster strategic corporate development (Alliance/BD and M&A) and managerial proficiencies. Goals involve growing high revenue + market share and executing joint deals in broad Rx areas, followed by completing an EMBA program.
Completed a Ph.D. in synthetic chemistry & an NSF Postdoctoral Fellowship at the University of Pennsylvania. Leveraged this expertise in expediting the drug discovery process for natural products synthesis on oncology molecules such as (+)-Discodermalide.
STRATEGIC PLANNING:
Piloted 10+ year market plan initiatives for Biotechnology companies throughout the Rx eco...
Mots-clés
gene therapy
neuroscience
humanized animals
cloning
pharmacology
translational randd
stem cells
gene editing
in vitro
cell engineering
in vivo
preclinical
metabolism
genomics
asymmetric catalysis
peroxides
zinc
biotechnology and pharmaceuticals
titanium
pharmaceutical drug
metal-mediated reactions
Tout plus